Analysis of blood markers for early colorectal cancer diagnosis
Open Access
- 22 September 2022
- journal article
- research article
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 13 (5) , 2259-2268
Abstract
Original Article Analysis of blood markers for early colorectal cancer diagnosis Juan Bayo Calero, Miguel Angel Castaño López, Pedro Germán Casado Monge, Jacobo Díaz Portillo, Ana Bejarano García, Francisco Navarro RoldánKeywords
This publication has 48 references indexed in Scilit:
- Validation of a Real-Time PCR–Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human PlasmaClinical Chemistry, 2014
- Controversies in Colorectal Cancer ScreeningDigestion, 2014
- Multitarget Stool DNA Testing for Colorectal-Cancer ScreeningNew England Journal of Medicine, 2014
- Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter StudyPLOS ONE, 2014
- Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancerWorld Journal of Gastrointestinal Oncology, 2014
- Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline EndorsementJournal of Clinical Oncology, 2013
- 8-hydroxy-2’-deoxyguanosine in colorectal adenocarcinoma – is it a result of oxidative stress?Medical Science Monitor, 2013
- Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancerBMC Medicine, 2011
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An UpdateAmerican Journal of Gastroenterology, 2008
- Precisión diagnóstica de la calprotectina fecal para predecir una colonoscopia patológicaMedicina Clinica, 2006